Miami Cancer Institute – New Advances in the Management of Pancreatic Cancer Evaluation - November 9, 2021

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

As a result of attending this conference, to what extent do you agree that you will be better able to: (rate the objectives) *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	N/A
Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care.	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - 5	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - 4	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - 3	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - 2	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - 1	Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care. - N/A
Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer.	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - 5	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - 4	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - 3	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - 2	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - 1	Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer. - N/A
Recognize the need for gastrointestinal follow-up for pancreatic cancer patients.	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - 5	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - 4	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - 3	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - 2	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - 1	Recognize the need for gastrointestinal follow-up for pancreatic cancer patients. - N/A

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Horacio Asbun, M.D.	Horacio Asbun, M.D. - 5	Horacio Asbun, M.D. - 4	Horacio Asbun, M.D. - 3	Horacio Asbun, M.D. - 2	Horacio Asbun, M.D. - 1
Michael Chuong, M.D.	Michael Chuong, M.D. - 5	Michael Chuong, M.D. - 4	Michael Chuong, M.D. - 3	Michael Chuong, M.D. - 2	Michael Chuong, M.D. - 1
Ripal Gandhi, M.D.	Ripal Gandhi, M.D. - 5	Ripal Gandhi, M.D. - 4	Ripal Gandhi, M.D. - 3	Ripal Gandhi, M.D. - 2	Ripal Gandhi, M.D. - 1
Govindarajan Narayanan, M.D.	Govindarajan Narayanan, M.D. - 5	Govindarajan Narayanan, M.D. - 4	Govindarajan Narayanan, M.D. - 3	Govindarajan Narayanan, M.D. - 2	Govindarajan Narayanan, M.D. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

Miami Cancer Institute – New Advances in the Management of Pancreatic Cancer Evaluation - November 9, 2021